SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RT who wrote (5595)2/23/1998 2:30:00 PM
From: LoLoLoLita  Read Replies (2) of 23519
 
>>As you can see we should have a REFILL rate of approximately
>>40,000 per week. Instead we have a refill rate of only 4,800.
>>This is a large discrepancy, and can only mean
>>one thing, dissatisfaction among muse users.

RT,

I'm sorry but I have to butt in here a little late.

You (and many others) are reading WAY too much into this weekly scrip
data. The reason is that what is called a "new" scrip is COMPLETELY
indistinguishable from (1) scrips to wholly new MUSE users (MUSE
virgins); (2) previous MUSE users who have used up their allowed
refills and gone back to a doctor (maybe a different doctor!) to
get a new scrip; and (3) previous MUSE users who haven't used up their refills but want to switch pharmacies (maybe trying mail order),
and who also went back for a "new" scrip.

The data just does not have the level of detail needed to
do what you are trying to do: namely, estimate the level of satisfaction of MUSE users.

Regards,

David
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News